Refactor Capital is a Burlingame, CA-based $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, aerospace, and more. The firm primarily invests in seed-stage companies.
As of March 2017, Refactor has invested in 20 software companies, half of them supporting healthcare and life sciences. Other areas represented in its portfolio are agriculture, financial, and legal services. The average check size is about $500,000, with the fund expecting to have around 40 to 50 companies in their portfolio.
As of January 2019, Refactor has 28 companies in its portfolio.
Associated Investment Funds
Funding Rounds Participated In
David Lee is back with a new fund: Refactor Capital
Refactor Capital cofounder highlights seed stage fund strategy - MedCity News